Report
MarketLine Department
EUR 150.41 For Business Accounts Only

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Astex Pharmaceuticals, Inc. (Astex or ‘the company’), a member of Otsuka Group, discovers, develops and commercializes cancer and central nervous system (CNS) therapies. It offers oncology product portfolio with multiple drugs in mid-late stage clinical development worldwide and CNS product portfolio of novel targeted therapeutics for defined neurodegenerative disease populations. Its product pipeline includes), a next generation DNA-hypomethylating agent; ASTX727, TAS1553, TAS1440, Azacitidine and Cedazuridine (ASTX030), an oral DNMT (DNA methyltransferase) inhibitor; ASTX029, an inhibitor of ERK 1/2; and ASTX660, a dual IAP (inhibitors of apoptosis proteins) antagonist. Astex has business presence in the UK and the US. The company is headquartered in Pleasanton, California, the US.

Scope

- Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Astex Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

- Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch